News & Trends
Procurar
Recentes
- M4Q(R2) The Common Technical Document for the Registration of Pharmaceuticals for Human Use: Quality
- EUDAMED Production Release Jan 28th 2026
- Guiding principles of good AI practice in drug development. January 2026
- ICH E6(R3) update – New training materials available (Jan 2026)
- 2025 EMA’s key recommendations in human medicines.
- Guiding principles of good AI practice in medicine development
- European Pharmacopoeia publishes new data quality framework
- FDA GUIDANCE DOCUMENT: Clinical Decision Support Software! Guidance for Industry and Food and Drug Administration Staff


SCOPE AND ORGANISATION
The M4Q(R2) guideline establishes the location and structure of quality information for registration applications of all medicinal products for human use. It supports various submission types, including those referring to or consisting of master files, and applies to both initial marketing authorisation and post-approval submissions. This guideline is structured to be flexible to accommodate all types of medicinal products and their components.